HOLOGIC INC Action · US4364401012 · HOLX · 879100 (XNAS) États-Unis · Healthcare — cotations et cours en temps réel, données d'entreprise, dividendes, fondamentaux et analyse de portefeuille IA sur MoneyPeak

Aperçu

Analyse alimentée par l’IA

Analyse fondamentale

Découvrez ce que disent vraiment les chiffres — avant le marché

Analyser maintenant

Sentiment des actualités

Les actualités d’aujourd’hui sont-elles un signal d’achat ou un avertissement ?

Analyser maintenant

Acheter / Conserver / Vendre

Faut-il acheter, conserver ou vendre ? Obtenez l’avis de l’IA dès maintenant.

Analyser maintenant

Évaluation des risques

Détectez les risques cachés avant qu’ils n’impactent votre portefeuille.

Analyser maintenant

Juste valeur

Cette action est-elle bon marché, correctement valorisée ou surévaluée ?

Analyser maintenant

Dernières analyses d’IA sur HOLOGIC INC

Résumé de la Note des Analystes

Conserver

Achat fort

Achat

Conserver

Vente

Vente forte

Pas de cours

Notation du Risque ESG

B- Bon

Flottant et Liquidité des Actions

Flottant Libre 99,09 %

Actions en Flottant 221,21 M

Actions en Circulation 223,24 M

Fonds investis

Les fonds suivants ont investi dans HOLOGIC INC :

Fonds Pacer Funds Trust - Pacer CSOP FTSE China A50 ETF	Vol. en millions 243,92	Part (%) 2,09 %
Fonds VictoryShares Nasdaq Next 50 ETF	Vol. en millions 2.608,82	Part (%) 1,81 %
Fonds ROBO Global Healthcare Technology and Innovation ETF	Vol. en millions 3.127,73	Part (%) 1,32 %
Fonds iShares US Medical Devices UCITS ETF USD (Acc)	Vol. en millions 642,89	Part (%) 1,15 %
Fonds John Hancock Multifactor Health Care ETF	Vol. en millions 381,28	Part (%) 0,78 %

Profil de l'entreprise pour HOLOGIC INC Action

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.